In focus · trending topic

FDA Advisory Committee

1 stories · following the connections

FDA Advisory Committee Votes That Efficacy Results of Cempra’s Solithromycin Outweigh Risks for Community-Acquired Bacterial Pneumonia

By Nasdaq OMXNov 5, 2016, 2:40 AM UTC